IRIS
DALLABONA, Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.402
AS - Asia 4.345
EU - Europa 3.098
SA - Sud America 549
Continente sconosciuto - Info sul continente non disponibili 290
AF - Africa 185
OC - Oceania 8
Totale 13.877
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.269
SG - Singapore 1.481
IT - Italia 1.135
CN - Cina 1.097
VN - Vietnam 659
SE - Svezia 440
IE - Irlanda 423
BR - Brasile 418
BD - Bangladesh 353
HK - Hong Kong 345
FI - Finlandia 225
FR - Francia 196
DE - Germania 170
ZA - Sudafrica 127
NL - Olanda 122
GB - Regno Unito 113
IN - India 73
CA - Canada 72
RU - Federazione Russa 71
TR - Turchia 64
UA - Ucraina 57
AR - Argentina 52
BE - Belgio 30
KR - Corea 29
IQ - Iraq 28
JP - Giappone 28
MX - Messico 28
AT - Austria 26
PK - Pakistan 24
PL - Polonia 24
ES - Italia 22
ID - Indonesia 22
EC - Ecuador 19
PH - Filippine 18
UZ - Uzbekistan 16
VE - Venezuela 15
CO - Colombia 13
MA - Marocco 12
SA - Arabia Saudita 12
LT - Lituania 11
CI - Costa d'Avorio 10
PE - Perù 10
TW - Taiwan 10
IL - Israele 9
IR - Iran 9
UY - Uruguay 9
AZ - Azerbaigian 8
EG - Egitto 8
KE - Kenya 8
TH - Thailandia 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
CL - Cile 7
CZ - Repubblica Ceca 6
DZ - Algeria 6
EU - Europa 6
JM - Giamaica 5
JO - Giordania 5
LB - Libano 5
NI - Nicaragua 5
PY - Paraguay 5
TN - Tunisia 5
MY - Malesia 4
PT - Portogallo 4
QA - Qatar 4
AL - Albania 3
BH - Bahrain 3
CR - Costa Rica 3
DK - Danimarca 3
GE - Georgia 3
HN - Honduras 3
LK - Sri Lanka 3
NP - Nepal 3
OM - Oman 3
PR - Porto Rico 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
CH - Svizzera 2
CY - Cipro 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LY - Libia 2
MD - Moldavia 2
PA - Panama 2
SN - Senegal 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BJ - Benin 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
ET - Etiopia 1
GR - Grecia 1
Totale 13.579
Salva come PNG Salva come JPEG
Città #
Singapore 756
Ashburn 578
San Jose 543
Dallas 423
Santa Clara 414
Dublin 410
Chandler 367
Hong Kong 324
Beijing 285
Parma 225
Ho Chi Minh City 204
New York 199
Council Bluffs 177
Boardman 176
Ann Arbor 170
Los Angeles 167
Dearborn 140
Hanoi 132
Johannesburg 111
Milan 91
Shanghai 88
Lauterbourg 87
Jacksonville 78
Nanjing 77
Hefei 75
Princeton 68
Buffalo 58
Bologna 56
Izmir 53
Wilmington 45
Moscow 44
Munich 41
Rome 41
Columbus 40
Helsinki 36
São Paulo 35
Jinan 31
Da Nang 30
Des Moines 30
Brussels 29
Nanchang 28
Shenyang 28
Nuremberg 25
San Mateo 25
Woodbridge 25
Marseille 24
Atlanta 23
Chicago 23
Haiphong 23
Tokyo 23
Toronto 22
Kunming 21
Biên Hòa 20
Houston 20
Changsha 19
Phoenix 19
Seoul 19
Catania 18
Guangzhou 18
London 18
The Dalles 18
Warsaw 18
Hebei 17
Reggio Emilia 17
Seattle 17
Turku 17
Belo Horizonte 16
Vienna 16
Brooklyn 15
Hangzhou 15
Montreal 15
Tashkent 15
Tianjin 15
Colchester 14
Falls Church 14
Turin 14
Zhengzhou 14
Bari 13
Figino 13
Frankfurt am Main 13
Modena 13
Naples 13
Redmond 13
Boston 12
Fontanellato 12
Hải Dương 12
Jakarta 12
Orem 12
Piacenza 12
Rio de Janeiro 12
Denver 11
Mexico City 11
Abidjan 10
Baghdad 10
Bengaluru 10
Chennai 10
Newark 10
Stockholm 10
Bremen 9
Brescia 9
Totale 7.904
Salva come PNG Salva come JPEG
Nome #
Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex 351
In Vivo Treatment with a Standardized Green Tea Extract Restores Cardiomyocyte Contractility in Diabetic Rats by Improving Mitochondrial Function through SIRT1 Activation 239
A yeast-based repurposing approach revealed modulation of dNTP pool as a therapeutic target to treat mitochondrial DNA depletion syndromes 221
Decline of cardiomyocyte contractile performance and bioenergetic function in socially stressed male rats 207
Childhood obsessive-compulsive disorder, epigenetics, and heterochrony: An evolutionary and developmental approach 205
Yeast models of human MTO1 variants confirm two diagnoses of mitochondrial modopathy 205
DNA polymerase [gamma] and disease: what we have learned from yeast 201
Repeated witness social stress causes cardiomyocyte contractile impairment and intracellular Ca2+ derangement in female rats 199
Sabotage at the powerhouse? Unraveling the Molecular Target of 2-Isopropylbenzaldehyde Thiosemicarbazone, a Specific Inhibitor of Aflatoxin Biosynthesis and Sclerotia Development in Aspergillus flavus, Using Yeast as a Model System 189
Defective PITRM1 mitochondrial peptidase is associated with Aβ amyloidotic neurodegeneration 184
Pathogenic variants in glutamyl-tRNAGlnamidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder 183
Drug Drop Test: How to Quickly Identify Potential Therapeutic Compounds for Mitochondrial Diseases Using Yeast Saccharomyces cerevisiae 182
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 177
A single nucleotide polymorphism in the DNA polymerase gamma gene of Saccharomyces cerevisiae laboratory strains is responsible for increased mitochondrial DNA mutability 176
A yeast-based repurposing approach for the treatment of mitochondrial DNA depletion syndromes led to the identification of molecules able to modulate the dNTP pool 173
Elongator-dependent modification of cytoplasmic tRNALysUUU is required for mitochondrial function under stress conditions 172
A homozygous mutation in LYRM7/MZM1L associated with early onset encephalopathy, lactic acidosis and severe reduction of mitochondrial complex III activity. 170
A Novel Homozygous YARS2 Mutation in Two Italian Siblings and a Review of Literature 167
Study of the effects of potentially beneficial molecules on the mitochondrial dNTP pool in a model of Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 167
Yeast as a model system to shed light on the role of the human disease protein Mpv17 166
The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases 165
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy 164
Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined Nonketotic Hyperglycinemia and Lipoate Deficiency 163
Yeast as a model of mitochondrial dysfunctions: neurodegenerative diseases and cancer. 163
Yeast as a model system for diseases associated with defective coenzyme a metabolism 163
Characterization of the BCS1L c.38A>G variant identified in a patient with Biörnstad syndrome 162
The identification of beneficial molecules for mitochondrial diseases: Saccharomyces cerevisiae as powerful model 161
De Novo DNM1L Pathogenic Variant Associated with Lethal Encephalocardiomyopathy—Case Report and Literature Review 157
Saccharomyces cerevisiae as a tool for studying mutations in nuclear genes involved in diseases caused by mitochondrial DNA instability 157
A yeast-based screening unravels potential therapeutic molecules for mitochondrial diseases associated with dominant ant1 mutations 153
Dominance of yeast aac2R96H and aac2R252G mutations, equivalent to pathological mutations in ant1, is due to gain of function 151
In-frame deletion in canine PITRM1 is associated with a severe early-onset epilepsy, mitochondrial dysfunction and neurodegeneration 150
Uncovering a Novel Pathogenic Mechanism of BCS1L in Mitochondrial Disorders: Insights from Functional Studies on the c.38A>G Variant. 149
Genetic and chemical rescue of the Saccharomyces cerevisiae phenotype induced by mitochondrial DNA polymerase mutations associated with progressive externalophthalmoplegia in humans 149
Yeast expression of mammalian Onzin and fungal FCR1 suggests ancestral functions of PLAC8 proteins in mitochondrial metabolism and DNA repair 149
Saccharomyces cerevisiae as a model for the identification of beneficial molecules for mitochondrial diseases. 149
YEAST MODEL FOR NOVEL AARS2 MUTATIONS ASSOCIATED WITH PROGRESSIVE LEUKOENCEPHALOPATHY AND CEREBELLAR ATAXIA 145
The power of yeast in modeling human mutations leading to mitochondrial disease:the case of ANT1, YARS2, DNM1L and LYRM7. 145
Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae 143
Mitochondrial Aminoacyl-tRNA Synthetase: The Power Of Yeast In Modeling Human Pathological Mutations 143
Genetic, physiological and molecular characterization of MPV17/SYM1 mutations in S. cerevisiae 143
Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome 143
DEFECTIVE MITOCHONDRIAL rRNA METHYLTRANSFERASE (MRM2) CAUSES A MELAS-LIKE SYNDROME 142
Sideroblastic anemia with myopathy secondary to novel, pathogenic missense variants in the YARS2 gene 142
The polymorphism Val158Met in the COMT gene: disrupted dopamine system in fibromyalgia patients? 139
Characterization of the Saccharomyces cerevisiae SYM1 gene, ortholog of the human desease gene MPV17 139
A simple organism to address big questions: how Saccharomyces cerevisiae can support mitochondrial medicine 138
Research of potentially therapeutic molecules for Hepatocerebral Mitochondrial DNA Depletion Syndrome caused by mutations in the MPV17 gene 138
De novo DNM1L pathogenic variant associated with lethal encephalocardiomyopathy and a literature review 137
Modeling human Coenzyme A synthase mutation in yeast reveals altered mitochondrial function, lipid content and iron metabolism 137
Saccharomyces cerevisiae as a system to discover beneficial molecules for mitochondrial diseases 135
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 134
Case Series and DARS2 Variant Analysis in Early Severe Forms With Unexpected Presentations 133
SYM1, the yeast ortholog of the MPV17 human disease gene, is required for TCA function, mtDNA stability and mitochondrial morphology in stress conditions 132
Transcriptomics on yeast models to deepen the knowledge of mitochondrial disease-associated pathways 131
Pathological Role of Mutations in Human MPV17: Saccharomyces cerevisiae as a Model System 131
Repurposing Drugs for Mitochondrial Disorders: A Yeast-Based Approach for Complex III Assembly Defects 130
Mitochondrial aminoacyl‐trna synthetase and disease: The yeast contribution for functional analysis of novel variants 130
Epigenetic analyses in forensic medicine: future and challenges 130
Modopathies Caused by Mutations in Genes Encoding for Mitochondrial RNA Modifying Enzymes: Molecular Mechanisms and Yeast Disease Models 130
A potential link between inflammatory profiles, clinical pain, pain catastrophizing and long‐term outcomes after total knee arthroplasty surgery 127
Mutations in the mitochondrial tryptophanyl-tRNA synthetase cause growth retardation and progressive leukoencephalopathy 126
Pain mechanistic networks: the development using supervised multivariate data analysis and implications for chronic pain 125
Saccharomyces cerevisiae, a model system to study the effect of mtDNA polymerase mutations associated with PEO in humans. 125
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 124
MUTATIONS IN THE GENES QRSL1, GATB, AND GATC ENCODING THE SUBUNITS OF GLUTAMYL-TRNA(GLN) AMIDOTRANSFERASE CAUSE A MITOCHONDRIAL DISORDER WITH LETHAL INFANTILE CARDIOMYOPATHY 124
The power of yeast in modeling human mutations: mitochondrial aminoacyl tRNA synthetases and mitochondrial tRNA modifiers 123
VARS2 and TARS2 Mutations in Patients with Mitochondrial Encephalomyopathies 123
TRMT5 Mutations Cause a Defect in Post-transcriptional Modification of Mitochondrial tRNA Associated with Multiple Respiratory-Chain Deficiencies 122
Functional analysis of missense DARS2 variants in siblings with leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation 120
An Unusual Case of SUCLA2-related Mitochondrial DNA Depletion Syndrome Who Presented with Hepatopathy Following Chemotherapy: Molecular Analysis and Functional Study 119
The power of yeast in modeling human mutations leading to mitochondrial disease 117
Sym1, the yeast ortholog of the MPV17 human disease protein, is a stress-induced bioenergetic and morphogenetic mitochondrial modulator 116
MTO1 mutations are associated with hypertrophic cardiomyopathy and lactic acidosis and cause respiratory chain deficiency in humans and yeast 115
Mitmed: a multicenter consortium for the identification and characterization of nuclear genes responsisble for human mitochondrial disorders 115
Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number 113
The yeast Saccharomyces cerevisiae as a model to deepen the knowledge about the mitochondrial metallopeptidase PITRM1 in health and disease 112
LYRM7 mutations cause a multifocal cavitating leukoencephalopathy with distinct MRI appearance. 111
Saccharomyces cerevisiae: a powerful organism to study mitochondrial diseases and support mitochondrial medicine 111
The Saccharomyces cerevisiae yeast as a model system to study the human mitochondrial DNA depletion syndromes (MDDS) 108
Predicting the contribution of novel POLG mutations to human disease through analysis in yeast model 108
Epigenetic alterations in prescription opioid misuse: New strategies for precision pain management 108
MITMED: A MULTICENTER CONSORTIUM FOR THE IDENTIFICATION AND CHARACTERIZATION OF NUCLEAR GENES RESPONSIBLE FOR HUMAN MITOCHONDRIAL DISORDERS 102
Yeast-based screening to discover therapies for Complex III assembly defects. 101
The Saccharomyces cerevisiae mitochondrial DNA polymerase and its contribution to the knowledge about human POLG-related disorders 101
Phenotypic, molecular, and functional characterization of COQ7-related primary CoQ10 deficiency: Hypomorphic variants and two distinct disease entities 100
Mitochondrial diseases and the role of the yeast models. 98
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis. 96
Targeting defects in assembly of the mitochondrial respiratory chain complexes by exploiting yeast models 95
Identification of potential therapeutic compounds for mitochondrial disorders due to mutations in mitochondrial respiratory chain assembly factors by exploiting yeast models 93
Role of ROS in mtDNA instability in ANT1-associated adPEO 90
The first recessive pathological mutation in the adenine nucleotide translocator: yeast as a model system 87
Yeast as a model system to propose therapies for Mitochondrial Complex III Deficiency 85
Novel (ovario) leukodystrophy related to AARS2 mutations 81
Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis 76
Yeast model of mitochondrial involvement of Aβ amyloidotic neurodegeneration 74
MTO1 MUTATIONS CAUSE RESPIRATORY CHAIN DEFICIENCY IN HUMANS AND YEAST 69
Sex-dependent salivary microRNA expression profiles and psychophysiological responses to acute stress in healthy adults 61
SYM1, l’ortologo di lievito del gene umano MPV17, codifica per una proteina indotta da stress che modula lo stato bioenergetico e morfogenetico del mitocondrio 48
From Genetics to Epigenetics: The Steps of a Path 47
Totale 13.825
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.014
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.014
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022381 0 21 1 27 14 27 35 36 14 33 28 145
2022/20231.457 138 150 101 95 132 155 28 78 502 6 51 21
2023/2024756 57 66 37 28 57 145 39 60 17 74 66 110
2024/20252.544 44 90 122 141 290 385 142 115 358 203 193 461
2025/20265.961 476 527 730 485 742 267 682 172 740 398 392 350
2026/2027638 272 366 0 0 0 0 0 0 0 0 0 0
Totale 13.877